Cadila Pharma to launch new biotech subsidiary, CPL Biologics Pvt Ltdpharmabiz.comThe JV will be responsible for clinical testing and registration of products that will be marketed and sold in India by the new company. ...and more »
jv
IFC to invest Rs 150 crore in Max India - Reuters India
IFC to invest Rs 150 crore in Max IndiaReuters India, India... IFC may get a 4-5% stake in the company. The stock closed at Rs 146.75 on Tuesday. Max India has a presence in areas like life insurance (a JV with New York Life), healthcare, clinical research, specialty plastics and health staffing. Continued...
Neuland Labs upbeat on high growth prospects - Business Standard
Neuland Labs upbeat on high growth prospectsBusiness Standard, IndiaThis year the focus will be on CRAMS both for drug discoveries and generic companies, clinical research and the new JV,” said Davuluri. The company is also looking at setting up its third manufacturing facility in India next year, a decision on the ...
Apollo Hospitals, Quintiles in JV for clinical research - Reuters India
Apollo Hospitals, Quintiles in JV for clinical researchReuters India, India - 20 minutes agoMUMBAI, Jan 31 (Reuters) - India's top listed hospital chain Apollo Hospitals Enterprise Ltd (APLH.BO: Quote, Profile, Research) has formed a joint venture ...
Ranbaxy, GSK in JV for initiate phase I trial - Business Standard
Ranbaxy, GSK in JV for initiate phase I trialBusiness Standard, India - 1 hour agoRanbaxy Laboratories has initiated phase I clinical trial of a lead compound for respiratory inflammation, a company release said today. ...Ranbaxy, GSK drug starts initial-stage trials Reuters IndiaRanbaxy's NDDR team achieves landmark in GSK research prog Moneycontrol.comRanbaxy Lab in poor health Moneycontrol.comall 7 news articles
Ranbaxy, GSK drug starts initial-stage trials - Reuters India
Ranbaxy, GSK drug starts initial-stage trialsReuters India, India - Jan 8, 2009MUMBAI, Jan 9 (Reuters) - India's Ranbaxy Laboratories Ltd (RANB.BO: Quote, Profile, Research) said on Friday it had started initial-stage clinical trials ...Ranbaxy's NDDR team achieves landmark in GSK research prog Moneycontrol.comRanbaxy, GSK in JV for initiate phase I trial Business StandardRanbaxy initiates studies on respiratory inflammation molecule Economic TimesIndopia - Moneycontrol.comall 11 news articles
Neuland Laboratories total income increases by 62% - Moneycontrol.com
Neuland Laboratories total income increases by 62%Moneycontrol.com, India - 6 hours agoOur JV with Cato Research US for undertaking their clinical trials in India is a step towards this direction.” (i) Contract Research and Manufacturing ...
Lilly shifts early-stage research to Indian JV - FierceBioResearcher
Lilly shifts early-stage research to Indian JVFierceBioResearcher, DC - 5 hours agoAnxious to push ahead with a slate of early-stage therapies, the pharma company struck a deal with India's Jubilant--a clinical research organization and ...
Eli Lily, Jubilant JV for phase-II clinical trials - Financial Express
Eli Lily, Jubilant JV for phase-II clinical trialsFinancial Express, India - 4 hours agoThe two companies already have a five-year drug discovery partnership since 2006 where Jubilant provides pre-clinical work for Eli Lilly. ...Eli Lilly, Jubilant Organosys form R&D joint venture Economic TimesEli Lilly, Jubilant in JV for drug R&D Business StandardJubilant Organosys & Lilly to form drug development JV Moneycontrol.com (press release)Reuters India - Hindustan Timesall 14 news articles
Neuland to invest Rs 40 cr in contract, clinical research services - Financial Express
Neuland to invest Rs 40 cr in contract, clinical research servicesFinancial Express, India - 46 minutes ago... and clinical research services which is being developed as a JV with Cato Research Inc, to conduct clinical trials in India for Cato Research worldwide. ...Neuland Laboratories Q4 net profit soars by 30% Moneycontrol.com (press release)Greaves’ FY08 net up 44% Howrah News Serviceall 4 news articles

